blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4112612

EP4112612 - INTERMEDIATE USEFUL FOR SYNTHESIS OF SGLT INHIBITOR AND METHOD FOR PREPARING SGLT INHIBITOR USING SAME [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  02.12.2022
Database last updated on 03.09.2024
FormerThe international publication has been made
Status updated on  03.09.2021
Most recent event   Tooltip05.03.2024Supplementary search reportpublished on 03.04.2024  [2024/14]
Applicant(s)For all designated states
Daewoong Pharmaceutical Co., Ltd.
35-14, Jeyakgongdan 4-gil, Hyangnam-eup
Hwaseong-si, Gyeonggi-do 18623 / KR
[N/P]
Former [2023/01]For all designated states
Daewoong Pharmaceutical Co., Ltd.
35-14, Jeyakgongdan 4-gil, Hyangnam-eup
Hwaseong-si
Gyenoggi-do 18623 / KR
Inventor(s)01 / YOON, Youn Jung
501ho 555dong, 20, Pureunsol-ro Suji-gu
Yongin-si Gyeonggi-do 16899 / KR
02 / YOON, Hee Kyoon
1102ho 208dong, 35, Yongam-ro Sangdang-gu
Cheongju-si Chungcheongbuk-do 28774 / KR
 [2023/01]
Representative(s)Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB
Ganghoferstraße 68 B
80339 München / DE
[2023/01]
Application number, filing date21761658.026.02.2021
[2023/01]
WO2021KR02507
Priority number, dateKR2020002452527.02.2020         Original published format: KR 20200024525
[2023/01]
Filing languageKO
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021172955
Date:02.09.2021
Language:KO
[2021/35]
Type: A1 Application with search report 
No.:EP4112612
Date:04.01.2023
Language:EN
[2023/01]
Search report(s)International search report - published on:KR02.09.2021
(Supplementary) European search report - dispatched on:EP04.03.2024
ClassificationIPC:C07D307/79, C07H1/00, C07H7/06, A61K31/343
[2024/14]
CPC:
C07D307/79 (EP,US); C07D307/82 (KR); C07D407/04 (US);
A61K31/343 (KR); C07H1/00 (EP); C07H1/02 (KR);
C07H17/04 (KR); C07H7/06 (EP); C07B2200/13 (KR,US) (-)
Former IPC [2023/01]C07D307/82, A61K31/343, C07H1/02, C07H17/04
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/01]
Validation statesMA27.09.2022
TitleGerman:ZWISCHENPRODUKT ZUR SYNTHESE EINES SGLT-INHIBITORS UND VERFAHREN ZUR HERSTELLUNG EINES SGLT-INHIBITORS DAMIT[2023/01]
English:INTERMEDIATE USEFUL FOR SYNTHESIS OF SGLT INHIBITOR AND METHOD FOR PREPARING SGLT INHIBITOR USING SAME[2023/01]
French:INTERMÉDIAIRE UTILE POUR LA SYNTHÈSE D'UN INHIBITEUR DE SGLT ET PROCÉDÉ DE PRÉPARATION D'UN INHIBITEUR DE SGLT L'UTILISANT[2023/01]
Entry into regional phase26.09.2022Translation filed 
27.09.2022National basic fee paid 
27.09.2022Search fee paid 
27.09.2022Designation fee(s) paid 
27.09.2022Examination fee paid 
Examination procedure27.09.2022Examination requested  [2023/01]
Fees paidRenewal fee
23.02.2023Renewal fee patent year 03
26.02.2024Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO2012165914  (GREEN CROSS CORP [KR], et al);
 [A]US2014274918  (CHOI SOONGYU [KR], et al);
 [AD]EP3473621  (DAE WOONG PHARMA [KR], et al)
International search[A]KR20140022086  (GREEN CROSS CORP [KR]);
 [A]KR20140114304  (GREEN CROSS CORP [KR]);
 [A]WO2016098016  (REDDY’S LAB LTD DR [IN]);
 [A]CN108530408  (WISDOM PHARMACEUTICAL CO LTD, et al);
by applicantKR20170142904
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.